[{"id":504564,"catid":3,"update_time":1753318494,"title":"药物联合疗法突破阴性乳腺癌脑转移治疗瓶颈","img":"","description":"本报讯 (记者李季 通讯员王晓凡)河南省肿瘤医院乳腺科副主任闫敏团队领衔的一项双队列、多中心Ⅱ期临床研究取得进展,证实国产创新药优替德隆联合贝伐珠单抗可显著延长人表皮生长因子受体-2(HER2)阴性乳腺癌脑转移患者的生命。该研究成果近日发表在《美国医学会杂志·肿瘤学》上。\r\r...","thumb":"","extend_content":"","toptitle_color":"","title_color":"","subtitle_color":"","url":"2025\/0724\/504564.html"},{"id":504563,"catid":3,"update_time":1753318457,"title":"自体RAK细胞疗法延缓早期肝癌患者术后复发","img":"","description":"本报讯 (记者吴倩 通讯员孔竞)北京医院生物治疗中心马洁教授团队联合中国医学科学院肿瘤医院肝胆外科主任周健国团队开展的一项研究,首次从临床结局与潜在机制两个层面,验证了由团队自主研发的自体RAK细胞疗法可延长早期肝细胞癌患者术后无复发生存期,展现出良好的安全性与应用前景,为早期肝...","thumb":"","extend_content":"","toptitle_color":"","title_color":"","subtitle_color":"","url":"2025\/0724\/504563.html"},{"id":504562,"catid":3,"update_time":1753318410,"title":"AI模型助力皮肤淋巴瘤精准诊断","img":"","description":"本报讯 (通讯员刘兆睿 刘洁 特约记者段文利)北京协和医院皮肤科刘洁主任医师团队联合北京航空航天大学谢凤英教授团队,研发出全球首个基于多模态人工智能(AI)的早期蕈样肉芽肿辅助诊断系统。该系统不仅能提升医生诊断早期皮肤淋巴瘤的能力,还提供了早期蕈样肉芽肿无创诊断的新路径,有望显著...","thumb":"","extend_content":"","toptitle_color":"","title_color":"","subtitle_color":"","url":"2025\/0724\/504562.html"},{"id":504535,"catid":3,"update_time":1753231637,"title":"我国学者揭示结直肠癌治疗潜在新靶点","img":"","description":"本报讯(特约记者 仰东萍 通讯员 曲瑞泽)北京大学第三医院肿瘤中心、普通外科付卫、张志鹏及内分泌科孙露露团队的一项研究揭示,肠道菌源核黄素通过抑制神经酰胺合成酶CERS3降低神经酰胺水平,从而延缓结直肠癌进展。该研究为基于肠道菌群代谢及菌源调控宿主代谢稳态的结直肠癌靶向治疗,提供...","thumb":"","extend_content":"","toptitle_color":"","title_color":"","subtitle_color":"","url":"2025\/0723\/504535.html"},{"id":504526,"catid":3,"update_time":1753231194,"title":"打造医学科技转化链的“创新枢纽”","img":"","description":"本报记者 胡彬 通讯员 曾海腾\r\r\r\t\r\r\r研究型医院聚焦临床疑难复杂疾病及重大疾病,坚持以临床为导向进行科学研究,并将科研成果转化为临床治疗能力与技术,持续推动诊疗方案革新与进步。作为新时代卫生健康事业高质量发展的重要载体,它成为推动医疗、教学、科研深度融合的重要创...","thumb":"","extend_content":"","toptitle_color":"","title_color":"","subtitle_color":"","url":"2025\/0723\/504526.html"},{"id":504525,"catid":3,"update_time":1753231117,"title":"全膝关节置换翻修术“上新了”","img":"","description":"近日,北京大学第三医院骨科关节外科主任田华教授团队在手术机器人系统辅助下,使用3D打印生物型假体,为一例膝关节置换术后无菌性松动患者进行了膝关节置换翻修术。手术过程顺利,患者术后恢复良好,术后5天即顺利出院。据检索,该术式尚属世界首例,也是国产手术机器人进行膝关节置换翻修术的首次...","thumb":"","extend_content":"","toptitle_color":"","title_color":"","subtitle_color":"","url":"2025\/0723\/504525.html"},{"id":504524,"catid":3,"update_time":1753231053,"title":"新技术引领甲状腺手术的无痕之变","img":"","description":"本报记者 夏海波\r\r\r\t\r\r\r在众多女性的认知里,脖颈是影响个人外在形象与气质的重要部位之一。然而,甲状腺癌等颈部疾病的治疗往往需要在脖颈处动刀,且容易留下明显的瘢痕。这些瘢痕常会成为患者尤其是年轻女性患者心中难以言说的伤痛。近年来,医学界以入路创新为突破口,积极探索...","thumb":"","extend_content":"","toptitle_color":"","title_color":"","subtitle_color":"","url":"2025\/0723\/504524.html"},{"id":504523,"catid":3,"update_time":1753230977,"title":"学科融合为肿瘤患者筑“心”防线","img":"","description":"罹患肿瘤,却“栽”在心脏?这对肿瘤患者来说并不是危言耸听。在肿瘤治疗手段迭代升级的当下,肿瘤患者生存期显著延长,但肿瘤本身及抗肿瘤治疗均可加重患者原有心血管疾病或引起新发心血管疾病;反过来,心血管疾病的存在也会明显影响肿瘤患者的长期生存。\r\r肿瘤心脏病学作为国际上一门新兴的交...","thumb":"","extend_content":"","toptitle_color":"","title_color":"","subtitle_color":"","url":"2025\/0723\/504523.html"},{"id":504486,"catid":3,"update_time":1753164074,"title":"我国在破伤风被动免疫领域实现突破","img":"","description":"本报讯(记者 崔芳 特约记者 钟艳宇)近日,国际期刊《自然·医学》以原创性论著形式发表了我国自主研发的全球首款重组抗破伤风毒素单克隆抗体——斯泰度塔单抗注射液的完整Ⅲ期临床试验结果。这标志着我国在破伤风被动免疫领域实现了重大突破。\r\r当前,破伤风仍是全球范围内,特别是破伤风疫...","thumb":"","extend_content":"","toptitle_color":"","title_color":"","subtitle_color":"","url":"2025\/0722\/504486.html"},{"id":504485,"catid":3,"update_time":1753164025,"title":"体外血小板制备或有全新策略","img":"","description":"本报讯(通讯员 吴煌 王奕璇 特约记者 朱广平)陆军军医大学陆军特色医学中心(大坪医院)输血医学科文爱清教授团队开展的一项最新研究,首次系统揭示了环状RNA circFUT8通过调控肌动蛋白骨架重排促进巨核细胞生成血小板的关键机制,或为体外血小板制备提供全新策略。近日,相关研究论...","thumb":"","extend_content":"","toptitle_color":"","title_color":"","subtitle_color":"","url":"2025\/0722\/504485.html"},{"id":504484,"catid":3,"update_time":1753163990,"title":"新研究系统梳理CAR-T细胞疗法不良反应","img":"","description":"本报讯(特约记者 严丽 通讯员 祝友文 刘坤)近日,中南大学湘雅医院肿瘤科朱红教授团队联合美国希望之城贝克曼研究所Steven T. Rosen(史蒂文·罗森)教授及中南大学湘雅医院血液科刘薇教授,在国际期刊《电子临床医学》发表论文《临床试验中CAR-T细胞疗法治疗癌症的相关不良...","thumb":"","extend_content":"","toptitle_color":"","title_color":"","subtitle_color":"","url":"2025\/0722\/504484.html"},{"id":504483,"catid":3,"update_time":1753163940,"title":"小胶质细胞替换可治疗致命脑病","img":"","description":"若将大脑比作精密运转的城池,小胶质细胞便是负责市容清理和治安巡逻的核心保卫者,而CSF1R基因恰似调控这些保卫者的中央指挥塔。CSF1R基因发生突变,会导致大量小胶质细胞罢工,部分细胞甚至从保卫者黑化为破坏者——破坏神经组织。\r\r本报讯(特约记者 孙国根)复旦大学上海医学院彭...","thumb":"","extend_content":"","toptitle_color":"","title_color":"","subtitle_color":"","url":"2025\/0722\/504483.html"},{"id":504446,"catid":3,"update_time":1753059785,"title":"静脉溶栓后尽早给予短效抗血小板药物","img":"","description":"本报讯(通讯员 陶春蓉 特约记者 方萍 方雯)中国科学技术大学附属第一医院(安徽省立医院)神经内科胡伟教授团队的一项最新研究发现,对于发病4.5小时内接受标准静脉溶栓治疗但不符合血管内取栓条件的急性非心源性缺血性脑卒中患者,在溶栓后早期(1小时内)加用短效静脉抗血小板药物替罗非班...","thumb":"","extend_content":"","toptitle_color":"","title_color":"","subtitle_color":"","url":"2025\/0721\/504446.html"},{"id":504445,"catid":3,"update_time":1753059716,"title":"增强实体瘤免疫疗效有新路径","img":"","description":"本报讯(记者 崔芳)肿瘤免疫治疗应用于实体瘤时,功效缺乏持久性,这主要囿于肿瘤微环境(TME)的存在。如何突破肿瘤微环境屏障,成为免疫治疗的关键挑战。近日,中国科学院国家纳米科学中心梁兴杰研究团队在《美国国家科学院院刊(PNAS)》上报道了基于仿生物理屏障的肿瘤免疫治疗新策略,为...","thumb":"","extend_content":"","toptitle_color":"","title_color":"","subtitle_color":"","url":"2025\/0721\/504445.html"},{"id":504425,"catid":3,"update_time":1752801182,"title":"三级淋巴器官是动脉粥样硬化独立风险因素","img":"","description":"本报讯(通讯员 干玎竹 陈恔 特约记者 段文利)我国学者在人类颈动脉粥样硬化斑块中鉴定出三级淋巴器官的存在,并揭示人类动脉粥样硬化斑块中三级淋巴器官的存在与患者出现脑卒中等症状密切相关,是颈动脉粥样硬化症状的独立风险因素。该研究由北京协和医院血管外科副主任刘暴团队、北京华大生命科...","thumb":"","extend_content":"","toptitle_color":"","title_color":"","subtitle_color":"","url":"2025\/0718\/504425.html"}]